Active, not recruitingPhase 2NCT05933603

Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down Syndrome

Studying Down syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Arizona
Intervention
Atomoxetine and Oxybutynin (ato-oxy)(drug)
Enrollment
36 enrolled
Eligibility
6-17 years · All sexes
Timeline
2023 – 2025

Study locations (1)

Collaborators

National Institutes of Health (NIH) · National Heart, Lung, and Blood Institute (NHLBI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05933603 on ClinicalTrials.gov

Other trials for Down syndrome

Additional recruiting or active studies for the same condition.

See all trials for Down syndrome →

← Back to all trials